Literature DB >> 1084815

Antibodies for T lymphocytes in systemic lupus erythematosus.

G Michlmayr, C Pathouli, C Huber, H Huber.   

Abstract

Sera of twenty-four patients with systemic lupus erythematosus were evaluated for antibodies cytotoxic for autologous lymphocytes. Such antibodies were domenstrable in twenty-two of these sera, whereas only one out of twenty patients with other connective tissue or lymphoproliferative disease showed a positive test. The antibodies remained detectable even when the patients went into remission. Sera containing the lymphocytotoxic antibodies were tested on cell fractions enriched for T or B lymphocytes. Primarily T lumphocytes wree affected by these antibodies. The presence of antibodies cytotoxic for T lymphocytes corresponded with a deficit of circulating T lymphocytes observed in most of our patients with systemic lupus erythematosys.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084815      PMCID: PMC1538498     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus.

Authors:  R B Lies; R P Messner; R C Williams
Journal:  Arthritis Rheum       Date:  1973 May-Jun

2.  Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis.

Authors:  B H Toh; I C Roberts-Thomson; J D Mathews; S Whittingham; I R Mackay
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

3.  [T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases].

Authors:  G Michlmayr; C Huber; U Fink; M Falkensammer; H Huber
Journal:  Schweiz Med Wochenschr       Date:  1974-06-08

4.  Lymphocyte surface immunoglobulins in autoimmune diseases.

Authors:  P Gergely; G Szegedi; B Fekete; G Szabó; G Petrányi
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

5.  Immunoglobulin and receptors for C3 on lymphocytes from patients with rheumatoid arthritis.

Authors:  O J Mellbye; R P Messner; J R DeBord; R C Williams
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

6.  Criteria for the classification of systemic lupus erythematosus--status 1972.

Authors:  A S Cohen; J J Canoso
Journal:  Arthritis Rheum       Date:  1972 Sep-Oct

7.  [Antibodies against autologous lymphocytes in lupus erythematosus].

Authors:  G Michlmayr; H Asamer; C Huber; H Huber
Journal:  Klin Wochenschr       Date:  1972-05-01

8.  Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.

Authors:  R P Messner; F D Lindström; R C Williams
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

9.  Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.

Authors:  R J Winchester; J B Winfield; F Siegal; P Wernet; Z Bentwich; H G Kunkel
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

10.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  9 in total

1.  Detection of antilymphocyte antibody with two-color method in systemic lupus erythematosus and its heterogeneous specificities against human T-cell subsets.

Authors:  K Okudaira; H Nakai; T Hayakawa; T Kashiwado; K Tanimoto; Y Horiuchi; T Juji
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

2.  Serum lymphocytotoxic activity in leprosy.

Authors:  F N Rasheed; M Locniskar; D J McCloskey; R S Hasan; T J Chiang; P Rose; R de Soldenhoff; H Festenstein; K P McAdam
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

3.  New lymphokines produced by SLE sera stimulated lymphocytes: the PNAF (polymorphonuclear activating factors).

Authors:  M T Labro-Bryskier; C Babin-Chevaye; J Hakim
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

Review 4.  Immunological characterization of lymphoproliferative disorders by membrane markers.

Authors:  H Huber; G Michlmayr; C Huber; M Falkensammer
Journal:  Klin Wochenschr       Date:  1976-08-01

5.  Biological activity of lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditis.

Authors:  W Pruzanski; H Capes; R Baur; B E Wenzel; V V Row; R Volpé
Journal:  J Endocrinol Invest       Date:  1984-02       Impact factor: 4.256

6.  Thymocytotoxic antibodies in patients with autoimmune hemolytic anemia, systemic lupus erythematosus and lymphoproliferative diseases.

Authors:  E Fagiolo
Journal:  Blut       Date:  1982-04

7.  E1Lymphocytopenia in pseudo-lupus-erythmetaosus syndrome.

Authors:  E Genth; W Hartl; H Hannig; E Steffens
Journal:  Blut       Date:  1976-10

8.  [Density distribution of human lymphocytes. I. Results of research on normal lymphoid tissue].

Authors:  C Huber; D Niederwieser; G Gastl; K Zier; H Braunsteiner
Journal:  Blut       Date:  1982-12

9.  The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.

Authors:  R Michalevicz; A Many; B Ramot; N Trainin
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.